Augmentation of CD134 (OX40)-dependent NK anti-tumour activity is dependent on antibody cross-linking-Reference-Cited by-同舟云学术

Augmentation of CD134 (OX40)-dependent NK anti-tumour activity is dependent on antibody cross-linking

Published:2018-02-02 Issue:1 Volume:8 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Turaj Anna H.,Cox Kerry L.,Penfold Christine A.,French Ruth R.,Mockridge C. Ian,Willoughby Jane E.,Tutt Alison L.,Griffiths Jordana,Johnson Peter W. M.,Glennie Martin J.,Levy Ronald,Cragg Mark S.^ORCID,Lim Sean H.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-018-20656-y.pdf

Reference37 articles.

1. Croft, M. Control of immunity by the TNFR-related molecule OX40 (CD134). Ann Rev Immunol. 28, 57–78 (2010).

2. Willoughby, J., Griffiths, J., Tews, I. & Cragg, M. S. OX40: Structure and function - What questions remain? Mol Immunol. 83, 13–22 (2017).

3. Kawamata, S., Hori, T., Imura, A., Takaori-Kondo, A. & Uchiyama, T. Activation of OX40 signal transduction pathways leads to tumor necrosis factor receptor-associated factor (TRAF) 2- and TRAF5-mediated NF-kappaB activation. J Biol Chem. 273, 5808–5814 (1998).

4. Arch, R. H. & Thompson, C. B. 4-1BB and Ox40 are members of a tumor necrosis factor (TNF)-nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor kappaB. Mol Cellular Biol. 18, 558–565 (1998).

5. Song, J. et al. The costimulation-regulated duration of PKB activation controls T cell longevity. Nat Immunol. 5, 150–158 (2004).

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NK Cell Degranulation Triggered by Rituximab Identifies Potential Markers of Subpopulations with Enhanced Cytotoxicity toward Malignant B Cells;International Journal of Molecular Sciences;2024-08-18

2. Impact of isotype on the mechanism of action of agonist anti-OX40 antibodies in cancer: implications for therapeutic combinations;Journal for ImmunoTherapy of Cancer;2024-07

3. Engaging stimulatory immune checkpoint interactions in the tumour immune microenvironment of primary liver cancers – how to push the gas after having released the brake;Frontiers in Immunology;2024-02-19

4. Crosstalk Between NK Cell Receptors and Tumor Membrane Hsp70‐Derived Peptide: A Combined Computational and Experimental Study;Advanced Science;2024-01-31

5. Single-cell functional genomics reveals determinants of sensitivity and resistance to natural killer cells in blood cancers;Immunity;2023-12